Overview of Pathophysiology of Cancer, Types, Causes, Treatment

Riam S. abbood; Rusul A. Alshammary; Marwa M. Al-Attar

doi:10.61704/jpr.v24i4.pp17-24

المؤلفون

Riam S. abbood Department of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq
Rusul A. Alshammary Department of Microbiology, College of Science, Mustansiriyah University, Baghdad, Iraq
Marwa M. Al-Attar Department of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq

DOI:

https://doi.org/10.61704/jpr.v24i4.pp17-24

الكلمات المفتاحية:

Pathophysiology، Types, Signs، Diagnosis، Treatment

الملخص

Cancer is a disease characterized by abnormal cell growth that can invade other parts of the body, forming tumors. While some tumors are benign and do not spread, malignant ones can metastasize. Cancer can develop in nearly any body part and exists in various forms, including lymphoma, sarcoma, leukemia, and carcinoma. Symptoms may include weight loss, persistent cough, lumps, unusual bleeding, and altered bowel movements, though these symptoms can have other causes. Over 100 types of cancer exist, often linked to prolonged exposure to carcinogens and the immune system's reparative response. Understanding cancer pathology is vital for its diagnosis, treatment, and prevention.

المراجع

Aleksijević, L., Aleksijević, M., Škrlec, I., Šram, M., Šram, M., and Talapko, J. (2022). Porphyromonas Gingivalis Virulence Factors and Clinical Significance in Periodontal Disease and Coronary Artery Diseases, Pathogens, 11(10), pp. 1173.

Al-Qahtani, A., Alhamlan, F., and Al-Qahtani, A. (2024). Pro-inflammatory and Anti-inflammatory Interleukins in Infectious Diseases: A Comprehensive Review, Tropical Medicine and Infectious Disease, 9(1), pp. 13.‏

Anand, U., Dey, A., Chandel, A., Sanyal, R., Mishra, A., Pandey, D. K., and de la Lastra, J. (2023). Cancer Chemotherapy and Beyond: Current Status, Drug Candidates, Associated Risks and Progress in Targeted Therapeutics, Genes & Diseases, 10(4), pp. 1367-1401.‏

Bansal, S., Gui, J., Merrill, C., Wong, J., Burak, K., and Wilson, S. (2019). Contrast-Enhanced US in Local Ablative Therapy and Secondary Surveillance for Hepatocellular Carcinoma, Radiographics, 39(5), pp. 1302-1322.‏

Bidkhori, G., Benfeitas, R., Klevstig, M., Zhang, C., Nielsen, J., Uhlen, M., and Mardinoglu, A. (2018). Metabolic Network-Based Stratification of Hepatocellular Carcinoma Reveals Three Distinct Tumor Subtypes, Proceedings of the National Academy of Sciences, 115(50), E11874-E11883.‏

Bispo, J., Pinheiro, P., and Kobetz, E. (2020). Epidemiology and Etiology of Leukemia and Lymphoma, Cold Spring Harbor Perspectives in Medicine, 10(6), pp. 1-22.‏

Boehm, E., Thon, C., Kupcinskas, J., Steponaitiene, R., Skieceviciene, J., Canbay, A., and Link, A. (2020). Fusobacterium Nucleatum Is Associated with Worse Prognosis in Lauren’s Diffuse Type Gastric Cancer Patients, Scientific Reports, 10(1), 16240.‏

Böttcher, M., Baur, R., Stoll, A., Mackensen, A., and Mougiakakos, D. (2020). Linking Immunoevasion and Metabolic Reprogramming in B-Cell–Derived Lymphomas, Frontiers in Oncology, 10, 594782.‏

Cowan, A., Green, D., Kwok, M., Lee, S., Coffey, D., Holmberg, L., and Libby, E. (2022). Diagnosis and Management of Multiple Myeloma: A Review, Jama, 327(5), pp. 464-477.‏

Creighton, C., Morgan, M., Gunaratne, P., Wheeler, D., Gibbs, R., Muzny, D. (2013). Comprehensive Molecular Characterization of Clear Cell Renal Cell Carcinoma, The Cancer Genome Atlas Research Network, Analysis Working Group: Baylor College of Medicine. Nature 499, pp. 43-49.

Cserni, G. (2020). Histological Type and Typing of Breast Carcinomas and the WHO Classification Changes over Time, Pathologica, 112(1), pp. 25.‏

Dailah, H., Hommdi, A., Koriri, M., Algathlan, E., and Mohan, S. (2024). Potential Role of Immunotherapy and Targeted Therapy in the Treatment of Cancer: A Contemporary Nursing Practice, Heliyon.‏

Damerell, V., Pepper, M., and Prince, S. (2021). Molecular Mechanisms Underpinning Sarcomas and Implications for Current and Future Therapy, Signal Transduction and Targeted Therapy, 6(1), pp. 246.‏

Das, S., Kundu, M., Jena, B., and Mandal, M. (2020). Causes of Cancer: Physical, Chemical, Biological Carcinogens, and Viruses, In: Biomaterials for 3D Tumor Modeling (pp. 607-641), Elsevier.‏

Delbue, S., Comar, M., and Ferrante, P. (2017). Review on the Role of the Human Polyomavirus JC in the Development of Tumors, Infectious Agents and Cancer, 12(1), pp. 1-14.‏

Desai, K., McManus, J., and Sharifi, N. (2021). Hormonal Therapy for Prostate Cancer, Endocrine Reviews, 42(3), pp. 354-373.‏

Fiorillo, L., Cervino, G., Laino, L., D’Amico, C., Mauceri, R., Tozum, T., and Cicciù, M. (2019). Porphyromonas Gingivalis, Periodontal and Systemic Implications: A Systematic Review, Dentistry Journal, 7(4), pp. 114.

Göbel, U., Schneider, D., Calaminus, G., Haas, R. J., Schmidt, P., Harms, D., and Makei, G. (2000). Germ-cell Tumors in Childhood and Adolescence, Annals of Oncology, 11(3), pp. 263-272.

Hanahan, D., and Weinberg, R. (2000). The Hallmarks of Cancer, Cell, 100(1), pp. 57-70.‏

Hong, S. (2018). Genetic and Epigenetic Alterations of Colorectal Cancer, Intestinal research, 16(3), pp. 327-337.‏

Huang, R., and Zhou, P. (2021). DNA Damage Repair: Historical Perspectives, Mechanistic Pathways and Clinical Translation for Targeted Cancer Therapy, Signal Transduction and Targeted Therapy, 6(1), pp. 254.‏

Jones, A. (2023). Pathology of Cancer: Causes, Pathophysiology, Diagnosis, Prevention and Treatment, J Med Surg Pathol, 8, pp. 267.

Jones, R., Latinovic, R., Charlton, J., and Gulliford, M. (2007). Alarm Symptoms in Early Diagnosis of Cancer in Primary Care: Cohort Study Using General Practice Research Database, Bmj, 334(7602), 1040.‏

Jose, J., Kumar, R., Harilal, S., Mathew, G., Parambi, D., Prabhu, A., and Mathew, B. (2020). Magnetic Nanoparticles for Hyperthermia in Cancer Treatment: An Emerging Tool, Environmental Science and Pollution Research, 27, pp. 19214-19225.‏

Khan, M., and Howden, C. (2019). Helicobacter Pylori and Related Diseases, In: Essential Medical Disorders of the Stomach and Small Intestine (pp. 141-154), Springer, Cham.‏

Kulke, M., Benson, A., Bergsland, E., Berlin, J., Blaszkowsky, L., Choti, M. A., and Dwyer, M. (2012). Neuroendocrine Tumors, Journal of the National Comprehensive Cancer Network, 10(6), pp. 724-764.‏

Lewis, T., and Dimri, M. (2020). Biochemistry, DNA Repair.‏

‏Liao, Y., Hong, X., Wu, A., Jiang, Y., Liang, Y., Gao, J., and Kou, X. (2021). Global Prevalence of Norovirus in Cases of Acute Gastroenteritis from 1997 to 2021: An Updated Systematic Review and Meta-Analysis, Microbial Pathogenesis, 161, 105259.

Liu, B., Zhou, H., Tan, L., Siu, K., and Guan, X. (2024). Exploring Treatment Options in Cancer: Tumor Treatment Strategies, Signal Transduction and Targeted Therapy, 9(1), pp. 175.

Liu, Y., Baba, Y., Ishimoto, T., Iwatsuki, M., Hiyoshi, Y., Miyamoto, Y., and Baba, H. (2019). Progress in Characterizing the Linkage between Fusobacterium Nucleatum and Gastrointestinal Cancer, Journal of Gastroenterology, 54, pp. 33-41.

Martinez, F., and Gordon, S. (2014). The M1 and M2 Paradigm of Macrophage Activation: Time for Reassessment, F1000prime Reports, 6.‏

Moens, U., Prezioso, C., and Pietropaolo, V. (2022). Functional Domains of the Early Proteins and Experimental and Epidemiological Studies Suggest a Role for the Novel Human Polyomaviruses in Cancer, Frontiers in Microbiology, 13, 834368.

Moses, C., Garcia-Bloj, B., Harvey, A., and Blancafort, P. (2018). Hallmarks of Cancer: The CRISPR Generation, European Journal of Cancer, 93, pp. 10-18.‏

Nabors, L., Portnow, J., Ahluwalia, M., Baehring, J., Brem, H., Brem, S., and Darlow, S. (2020). Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology, Journal of the National Comprehensive Cancer Network, 18(11), pp. 1537-1570.‏

Režen, T., Rozman, D., Kovács, T., Kovács, P., Sipos, A., Bai, P., and Mikó, E. (2022). The Role of Bile Acids in Carcinogenesis, Cellular and Molecular Life Sciences, 79(5), pp. 243.‏

Saginala, K., Barsouk, A., Aluru, J., Rawla, P., and Barsouk, A. (2021). Epidemiology of Melanoma, Medical Sciences, 9(4), pp. 63.‏

Saini, A., Kumar, M., Bhatt, S., Saini, V., and Malik, A. (2020). Cancer Causes and Treatments, Int. J. Pharm. Sci. Res, 11(7), pp. 3121-3134.‏

Saletta, F., Dalla Pozza, L., and Byrne, J. (2015). Genetic Causes of Cancer Predisposition in Children and Adolescents, Translational pediatrics, 4(2), pp. 67.‏‏

Schiffman, M., Doorbar, J., Wentzensen, N., De Sanjosé, S., Fakhry, C., Monk, B., and Franceschi, S. (2016). Carcinogenic Human Papillomavirus Infection, Nature Reviews Disease Primers, 2(1), pp. 1-20.

Shapley, M., Mansell, G., Jordan, J., and Jordan, K. (2010). Positive Predictive Values of ≥ 5% in Primary Care for Cancer: Systematic Review, British Journal of General Practice, 60(578), pp. e366-e377.‏

Shechter, O., Sausen, D., Gallo, E., Dahari, H., and Borenstein, R. (2022). Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments, International Journal of Molecular Sciences, 23(22), 14389.

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., and Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA: A Cancer Journal for Clinicians, 71(3), pp. 209-249.‏

Thind, S., Shibib, D., and Gentry, C. (2021). The Effect of Nomenclature Revision of Streptococcus Bovis to Streptococcus Gallolyticus on Subsequent Colon Cancer Screening, In: Open Forum Infectious Diseases (Vol. 8, No. 9, p. ofab426). US: Oxford University Press.

Torne, A., and Robertson, E. (2024). Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers, Cancers, 16(5), pp. 991.

Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., and Ponten, F. (2017). A Pathology Atlas of the Human Cancer Transcriptome, Science, 357(6352), eaan2507.‏

Vaiserman, A., Koliada, A., Zayachkivska, A., and Lushchak, O. (2020). Nanodelivery of Natural Antioxidants: An Anti-Aging Perspective, Frontiers in Bioengineering and Biotechnology, 7, pp. 447.

Van Dyne, E. (2018). Trends in Human Papillomavirus–Associated Cancers—United States, 1999–2015, MMWR. Morbidity and Mortality Weekly Report, 67.

Wang, H., and He, X. (2018). Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells and Tumor, Targeted Drug Delivery: Methods and Protocols, pp. 59-67.

Wang, H., Naghavi, M., Allen, C., Barber, R., Carter, A., Casey, D., and Liang, X. (2016). Global, Regional, and National Life Expectancy, All-Cause Mortality, and Cause-Specific Mortality for 249 Causes of Death, 1980 - 2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet, 388(10053), pp. 1459-1544.‏

Xu, X., Duan, F., Ng, S., Wang, H., Wang, K., Li, Y., and Xu, E. (2022). Clinicopathological and Prognostic Value of lncRNAs Expression in Gastric Cancer: A Field Synopsis of Observational Studies and Databases Validation, Medicine, 101(40), e30817.‏

Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., and Li, Y. (2021). Inflammation and Tumor Progression: Signaling Pathways and Targeted Intervention, Signal Transduction and Targeted Therapy, 6(1), pp. 263.‏